CareTrust REIT, Inc. $CTRE Shares Sold by Alyeska Investment Group L.P.

Key Points

• Alyeska Investment Group cut its CareTrust REIT stake by 11% in the second quarter, selling 175,111 shares and retaining 1.42 million shares valued at approximately $57.3 million.
• Institutional investors and hedge funds own 87.77% of CareTrust REIT, with BlackRock initiating a position worth about $1.64 billion and several other major firms increasing their holdings.
• CareTrust REIT reported quarterly EPS of $0.51 on $161.35 million in revenue, maintained a $0.39 quarterly dividend yielding about 4.0%, and carries a “Moderate Buy” consensus rating with an average analyst price target of $44.82.

Alyeska Investment Group L.P. reduced its holdings in CareTrust REIT, Inc. (NYSE:CTRE - Free Report) by 11.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,419,026 shares of the company's stock after selling 175,111 shares during the period. Alyeska Investment Group L.P. owned approximately 0.60% of CareTrust REIT worth $57,258,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of CareTrust REIT during the 2nd quarter worth $1,643,290,000. State Street Corp increased its position in shares of CareTrust REIT by 1.8% during the 4th quarter. State Street Corp now owns 12,426,213 shares of the company's stock worth $453,411,000 after purchasing an additional 219,641 shares during the last quarter. Wellington Management Group LLP raised its holdings in CareTrust REIT by 18.1% in the 4th quarter. Wellington Management Group LLP now owns 12,355,966 shares of the company's stock valued at $446,792,000 after buying an additional 1,893,143 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in CareTrust REIT by 108.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,493,898 shares of the company's stock valued at $234,820,000 after buying an additional 3,379,732 shares during the period. Finally, Geode Capital Management LLC lifted its position in CareTrust REIT by 7.2% in the fourth quarter. Geode Capital Management LLC now owns 6,092,398 shares of the company's stock valued at $220,332,000 after buying an additional 409,411 shares during the last quarter. 87.77% of the stock is currently owned by institutional investors and hedge funds.

CareTrust REIT Stock Performance

NYSE:CTRE opened at $39.02 on Monday. CareTrust REIT, Inc. has a 52 week low of $32.79 and a 52 week high of $43.62. The company has a fifty day simple moving average of $40.71 and a two-hundred day simple moving average of $39.78. The company has a quick ratio of 0.57, a current ratio of 0.57 and a debt-to-equity ratio of 0.27. The company has a market cap of $9.22 billion, a price-to-earnings ratio of 24.54, a price-to-earnings-growth ratio of 1.54 and a beta of 0.75.

CareTrust REIT (NYSE:CTRE - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.51 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.51. CareTrust REIT had a return on equity of 8.52% and a net margin of 62.19%.The firm had revenue of $161.35 million during the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. As a group, equities analysts anticipate that CareTrust REIT, Inc. will post 2.05 earnings per share for the current fiscal year.

CareTrust REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date of this dividend was Tuesday, June 30th. CareTrust REIT's payout ratio is 98.11%.

Analysts Set New Price Targets

CTRE has been the topic of a number of research analyst reports. Royal Bank Of Canada lowered CareTrust REIT from an "outperform" rating to a "sector perform" rating and cut their target price for the company from $44.00 to $43.00 in a research report on Friday, August 14th. Raymond James Financial assumed coverage on CareTrust REIT in a research report on Tuesday, June 16th. They set an "outperform" rating and a $43.00 price target for the company. Weiss Ratings cut CareTrust REIT from a "buy (a-)" rating to a "buy (b+)" rating in a research note on Friday, August 21st. KeyCorp reiterated an "overweight" rating and issued a $46.00 price objective on shares of CareTrust REIT in a report on Friday, May 29th. Finally, Citigroup reissued a "market outperform" rating on shares of CareTrust REIT in a research note on Wednesday, June 10th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $44.82.

About CareTrust REIT

CareTrust REIT, Inc is a real estate investment trust based in Deerfield Beach, Florida, specializing in the ownership, acquisition and management of net-leased healthcare properties. The company primarily focuses on seniors housing and post-acute care facilities, entering into long-term, triple-net lease agreements with leading operators in the skilled nursing, assisted living, memory care, inpatient rehabilitation and specialty hospital sectors. Through its portfolio, CareTrust REIT aims to provide investors with stable and predictable rental income while supporting the ongoing demand for quality healthcare real estate across the United States.

Since its initial public offering in September 2013, CareTrust REIT has pursued a disciplined acquisition strategy, targeting properties in primary and select secondary markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.